Alofisel (darvadstrocel) – Withdrawal from EU market
19/12/2024
Medicines for human use
Product information update (PIU)
This update is to inform healthcare professionals about the withdrawal of Alofisel (darvadstrocel) from the EU market.
Please see the document inked below for further information.
Product information
- Active substance
- Expanded human allogeneic mesenchymal adult stem
- Authorisation holder
- Takeda Pharma A/S
- Authorisation number
-
EU/1/17/1261/001
- Human or veterinary medicine
- Human medicine